首佳科技(00103.HK)擬委任信永中和爲核數師
格隆匯5月9日丨首佳科技(00103.HK)公佈,公司現任核數師羅兵鹹永道的任期將於即將舉行的公司股東周年大會結束時屆滿。考慮到羅兵鹹永道自2018年8月1日起擔任公司核數師,公司董事會及審覈委員會認爲,現爲輪換本公司核數師的適當時機,以秉承良好企業管治及保持公司核數師之獨立性。該輪換將增強公司外部審計的獨立性,並符合公司及公司股東的整體最佳利益。
董事會已根據審覈委員會推薦建議,決定於羅兵鹹永道退任後,建議委任信永中和爲公司核數師。視乎股東於股東周年大會上通過普通決議案批準,並在完成信永中和之承接新客戶程序後,信永中和作爲公司核數師的任期應自即將舉行之股東周年大會結束起生效,直至公司下一屆股東周年大會結束。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.